Imidaprilate (imidaprilat) is the active metabolite of the prodrug imidapril, an angiotensin-converting enzyme (ACE) inhibitor. It works by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced blood pressure. Primarily used in the treatment of hypertension, it also aids in managing heart failure by improving cardiac function and survival rates. Additionally, it helps prevent diabetic nephropathy by protecting renal function. As a specialty chemical and pharmaceutical intermediate, it is supplied at high purity (≥98%) for research, development, and therapeutic applications under medical supervision.